about
Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party oRole of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.New approaches for measuring coagulation.Venous thrombosis at unusual sites and the role of thrombophilia.Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis.Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH.A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty.Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review.Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users.Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation.Ruxolitinib-associated infections: A systematic review and meta-analysis.Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study.A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia.Abnormalities of homocysteine and B vitamins in the nephrotic syndromePlatelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet countA rare case of autoimmune haemolytic anaemia due to warm IgA autoantibodies with reticulocytopeniaPolymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta-analysisPrevalence of factor V Leiden and G20210A prothrombin mutation in the Dutch Famine Birth Cohort: a possible survival advantage?Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplastyMolecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia
P50
Q33421065-AD4BF44D-3B72-45CA-B57B-482EB27D91BBQ33558748-80370E86-04E6-43C2-AA82-0D92AD51832AQ34532041-62E105DC-3914-4930-B152-51205F59305FQ36473061-D8F0781D-69DD-4A17-B159-B628C02B80E2Q36928090-151C47EA-3CAB-467C-BB7F-EED924394190Q37418414-75BBCCA6-8D10-426A-A8E9-0D974C2EBDFFQ37578073-5BFEE534-6278-4A31-A9F7-6FB31E586013Q37988150-8D69FFF2-48A9-46E0-9560-F626219D3435Q38097973-EDAA7285-597A-4E3F-AD61-06AC6C94FDB3Q38234163-A2392D4B-F3AA-4D3B-83F0-276523A926C3Q38775883-ABD962EE-DC59-43F6-9E6F-A7D2BF7DA526Q44794623-BA947510-0408-44FD-B5EA-CC481AC8EB8EQ47824825-9A8765D1-8362-46D5-A1BD-6B44007739FBQ48177340-8B1B0ED5-FEF2-462A-A4A8-790A6F1D7545Q48278553-D1E0F900-8AA8-4F12-B15E-4257C8F48560Q51684693-164DED90-5444-44D9-B9B2-D504004A112CQ54329508-C2CDA384-1D81-4031-AAFF-A09367C430B9Q54681025-2416FA35-B2C6-4E39-A194-257A6EEABD5AQ60729413-91427C3A-F562-4B7F-B023-EDF408ACC41AQ80292680-AFE32A7B-2D2D-48DB-B86A-35F573214A6CQ80625438-70CA9099-2517-4809-A8AA-5279EF27B222Q81796919-674C01F0-D91E-47BF-A81A-4FC986647956Q84213191-ED227D85-C1E1-49C0-B736-7882ECF3EA74Q87254485-CAD24C71-C061-4ACE-9A30-560D3281EE51Q90381429-90A8B49E-AA8F-4C16-9F80-1E78EFDECD5C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
F Lussana
@ast
F Lussana
@en
F Lussana
@es
F Lussana
@nl
type
label
F Lussana
@ast
F Lussana
@en
F Lussana
@es
F Lussana
@nl
prefLabel
F Lussana
@ast
F Lussana
@en
F Lussana
@es
F Lussana
@nl
P106
P1153
6506596229
P31
P496
0000-0002-6510-8616